Also, TNF-α and IL-6, overexpressed in CKD patients, exert their catabolic effects with the stimulation of the ubiquitin proteasome complex and through the downregulation of anabolic pathways mediated by IGF and the dysregulation of the mTOR pathway [43]. Here, IL6 is linked to chronic kidney disease.